ADMA BioCenters
David Roby is currently working as the Managing Director at ADMA BioCenters since November 2022. Prior to that, David held positions at Octapharma Plasma, Inc. from July 2010 to March 2023, where David served as a Center Director and Assistant Manager. Before joining Octapharma Plasma, Inc., David worked as an Assistant Manager at International BioResources, LLC from January 2009 to July 2010.
This person is not in any teams
This person is not in any offices
ADMA BioCenters
ADMA BioCenters are FDA-licensed facilities dedicated to the collection of human plasma from donors. Human plasma is used to make special medications to help treat and prevent infections in patients. ADMA BioCenters operates as a wholly-owned subsidiary of our parent company ADMA Biologics, an end-to-end commercial biopharmaceutical company committed to manufacturing and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart.